Ilona Hromadnikova
Overview
Explore the profile of Ilona Hromadnikova including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
73
Citations
1115
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hromadnikova I, Kotlabova K, Krofta L
Front Med (Lausanne)
. 2024 Dec;
11:1469855.
PMID: 39691371
Background: Placenta previa is the abnormal implantation of the placenta into the lower segment of the uterus, is associated with adverse maternal and fetal outcomes such as placenta accreta spectrum...
2.
Hromadnikova I, Kotlabova K, Krofta L
Front Cell Dev Biol
. 2024 Sep;
12:1461547.
PMID: 39296937
Introduction: This study aimed to establish efficient, cost-effective, and early predictive models for adverse pregnancy outcomes based on the combinations of a minimum number of miRNA biomarkers, whose altered expression...
3.
Matraszek V, Herman H, Hromadnikova I
Ceska Gynekol
. 2024 Jul;
89(3):237-244.
PMID: 38969520
Aim And Methodology: To provide a comprehensive review on new findings and current recommendations regarding antiphospholipid antibodies with particular emphasis on clinical impact on gestation. Conclusion: Antiphospholipid antibodies are an...
4.
Hromadnikova I
Int J Mol Sci
. 2024 Mar;
25(5).
PMID: 38473735
This Special Issue mainly focuses on preeclampsia (PE), haemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome, gestational diabetes mellitus (GDM), foetal growth restriction (FGR), small-for-gestational-age foetuses (SGA), miscarriage,...
5.
Hromadnikova I, Kotlabova K, Krofta L
Mol Cell Probes
. 2023 Nov;
72:101941.
PMID: 37951512
We established efficient first trimester prediction models for small-for-gestational age (SGA) and fetal growth restriction (FGR) without the presence of preeclampsia (PE) regardless of the gestational age of the onset...
6.
Hromadnikova I, Kotlabova K, Krofta L
Int J Mol Sci
. 2023 Jun;
24(12).
PMID: 37373283
We evaluated the potential of cardiovascular-disease-associated microRNAs to predict in the early stages of gestation (from 10 to 13 gestational weeks) the occurrence of a miscarriage or stillbirth. The gene...
7.
Hromadnikova I
Int J Mol Sci
. 2023 Mar;
24(6).
PMID: 36982657
In this special edition (closed on 31 October 2022), 4 reviews, 13 original papers, 1 communication, and 1 case report are published [...].
8.
Hromadnikova I, Kotlabova K, Krofta L
Int J Mol Sci
. 2023 Mar;
24(6).
PMID: 36982251
We evaluated the potential of cardiovascular-disease-associated microRNAs for early prediction of HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Gene expression profiling of 29 microRNAs was performed on whole...
9.
Hromadnikova I, Kotlabova K, Krofta L
Biomedicines
. 2022 Oct;
10(10).
PMID: 36289853
The goal of the study was to establish an efficient first-trimester predictive model for any type of preterm birth before 37 gestational weeks (spontaneous preterm birth (PTB) or preterm prelabor...
10.
Hromadnikova I, Kotlabova K, Krofta L
Int J Mol Sci
. 2022 Sep;
23(18).
PMID: 36142536
We assessed the diagnostic potential of cardiovascular disease-associated microRNAs for the early prediction of gestational diabetes mellitus (GDM) in singleton pregnancies of Caucasian descent in the absence of other pregnancy-related...